Last Updated : October 19, 2020
Details
FilesProject Status:
Completed
Project Line:
Reference List
Project Sub Line:
Reference List
Project Number:
RA1141-000
Question
- What is the clinical utility of positron emission tomography–computed tomography in patients to detect coronary artery disease and to measure coronary flow reserve?
- What is the cost-effectiveness of positron emission tomography–computed tomography in patients to detect coronary artery disease and to measure coronary flow reserve?
- What is the clinical evidence regarding the safety of positron emission tomography–computed tomography in patients to detect coronary artery disease and to measure coronary flow reserve?
- What is the diagnostic accuracy of positron emission tomography–computed tomography in patients to detect coronary artery disease and to measure coronary flow reserve?
Key Message
One randomized controlled trial and one non-randomized study were identified regarding the clinical utility of positron emission tomography–computed tomography in patients to detect coronary artery disease and to measure coronary flow reserve. In addition, three systematic reviews (two with meta-analyses) and 14 non-randomized studies were identified regarding the diagnostic accuracy of positron emission tomography–computed tomography in patients to detect coronary artery disease and to measure coronary flow reserve. One of the non-randomized studies also addressed the safety of positron emission tomography–computed tomography in patients to detect coronary artery disease and to measure coronary flow reserve. No relevant literature was identified regarding the cost-effectiveness of positron emission tomography–computed tomography in patients to detect coronary artery disease and to measure coronary flow reserve.
Files
Last Updated : October 19, 2020